NCT06484179 Enhancing Motivation to Quit Smoking Via Self-Help Intervention Targeted to Cancer Type
| NCT ID | NCT06484179 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2024-08-28 |
| Primary Completion | 2027-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2024-08-28 with a primary completion date of 2027-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this research study is assess feasibility and acceptability of a recently developed brief self-help intervention targeted by cancer type to increase motivation to quit smoking.
Eligibility Criteria
Inclusion Criteria: * Individuals who smoke and recently (i.e., within 6 months) received a diagnosis of breast, colorectal, gynecological, skin melanoma, or bladder cancer (n = 20 per cancer type). (Investigators will consider smokers individuals who report having smoked ≥1 cigarette in the past 30 days.) * Able to read/write English; * Able to give informed consent; * Not currently enrolled in a smoking cessation program; * Age ≥18 years old. Exclusion Criteria: * Male patients diagnosed with breast cancer will be excluded as lifetime risk for breast cancer in men is far below 1%
Contact & Investigator
Ursula Martinez, PhD
PRINCIPAL INVESTIGATOR
Huntsman Cancer Institute
Frequently Asked Questions
Who can join the NCT06484179 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06484179 currently recruiting?
Yes, NCT06484179 is actively recruiting participants. Contact the research team at Heather.Anderson@hci.utah.edu for enrollment information.
Where is the NCT06484179 trial being conducted?
This trial is being conducted at Salt Lake City, United States.
Who is sponsoring the NCT06484179 clinical trial?
NCT06484179 is sponsored by University of Utah. The principal investigator is Ursula Martinez, PhD at Huntsman Cancer Institute. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.